Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007342
Chunk: 115

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 115
---
 beneficially own any shares of our common stock.    
 Thomas Walsh and Jonathan Juchno, the Managing Partners of C/M Capital Master Fund, LP, are deemed to be beneficial owners of all of the 
 shares of common stock owned by C/M Capital Master Fund, LP. Messrs. Walsh and Juchno have shared voting and investment power over the   
 shares being offered hereunder in connection with the transactions contemplated under the Purchase Agreement. C/M Capital Master Fund,   
 LP is not a registered broker-dealer or an affiliate of a registered broker-dealer.                                                      |

| 74 |

<div align='center'>PLAN OF DISTRIBUTION</div>

The securities offered by this prospectus are being
offered by the Selling Shareholder. The shares may be sold or distributed from time to time by the Selling Shareholder directly to one
or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of
sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of our
common stock offered by this prospectus could be effected in one or more of the following methods:

| · | ordinary brokerage transactions; |

| · | transactions involving cross or block trades; |

| · | through brokers, dealers, or underwriters who may act solely as agents; |

| · | “at the market” into an existing market for our securities; |

| · | in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected 
 through agents;                                                                                                                   |

| · | in privately negotiated transactions; or |

| · | any combination of the foregoing. |

In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state’s registration or qualification requirement is available and complied with.

The Selling Shareholder is
an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.

The Selling Shareholder has
informed us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our Depositary Shares that
it has acquired and may in the future acquire from us pursuant to the Purchase Agreement. Such sales will be made at